Artemisinin combination therapies

Simple item page
dc.contributor.authorMutabingwa, Theonest K.
dc.date.accessioned2020-10-13T07:30:03Z
dc.date.available2020-10-13T07:30:03Z
dc.date.issued2006
dc.description.abstractGlobal mortality from Plasmodium falciparum malaria has always been enormous, and has increased in recent decades as chloroquine-resistant parasites spread worldwide. Alarms were raised further when parasites developed resistance to sulfadoxine-pyrimethamine soon after it was introduced to replace chloroquine in many areas. To protect the few remaining drugs in the malaria armamentarium, combination therapy is now touted, particularly combinations that include artemisinin derivatives, widely known as artemisinin combination therapies (ACTs).en_US
dc.identifier.citationDuffy, P.E. and Mutabingwa, T.K., 2006. Artemisinin combination therapies. The Lancet, 367(9528), pp.2037-2039.en_US
dc.identifier.otherDOI:https://doi.org/10.1016/S0140-6736(06)68900-9
dc.identifier.urihttp://hdl.handle.net/123456789/649
dc.language.isoenen_US
dc.publisherThe Lanceten_US
dc.subjectPlasmodium falciparumen_US
dc.subjectArtemisininen_US
dc.subjectSulfadoxine-pyrimethamineen_US
dc.titleArtemisinin combination therapiesen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The Lance1.pdf
Size:
12.95 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Journals

Total Collections: 1